Siblings Conference Papers/Meeting Abstract [8/8] Collection Statistics Item counts issued in 3 years:25(78.12%) Items With Fulltext:32(100.00%) Download counts of the item Download times greater than 0:32(100.00%) Download times greater than 100:25(78.12%) Total Bitstream Download Counts:5671(85.99%) Last Update: 2024-12-01 10:32 Top Upload Loading... Top Download Loading... Recent Submissions Pathological response following neo... Clinical outcomes and histologic fi... Cytoplasmic lipid droplets predict ... A phase 1 study of biweekly nab-pac... Outcomes of post-immunotherapy dura... Impact of previous S-1 treatment on... Neuron-derived neurotensin promotes... Germline mutations of homologous re... Systemic treatments in pancreatic c... Pancreatic cancer cell-derived sema...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 1-10 of 32. (4 Page(s) Totally) 1 2 3 4 > >> View [10|25|50] records per page

Date	Title	Relation
2024-11	Cytoplasmic lipid droplets predict worse prognosis in diffuse large B-cell lymphoma: Next-generation sequencing deciphering lipogenic genes	American Journal of Surgical Pathology. 2024 Nov 1;48(11):1425-1438.
2024-11	Pathological response following neoadjuvant immune checkpoint inhibitors in patients with hepatocellular carcinoma: A cross-trial, patient-level analysis	Lancet. Oncology. 2024 Nov;25(11):1465-1475.
2024-10	A phase 1 study of biweekly nab-paclitaxel/oxaliplatin/S-1/LV for advanced upper gastrointestinal cancers: TCOG T1216 study	Oncologist. 2024 Oct 3;29(10):e1396-e1405.
2024-08-28	Clinical outcomes and histologic findings of patients with hepatocellular carcinoma with durable partial response or durable stable disease after receiving atezolizumab plus bevacizumab	Journal of Clinical Oncology. 2024 Aug 28;Article in Press.
2024-06	Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendation	Biomedical Journal. 2024 Jun;47(3):Article number 100696.
2024-05	Impact of previous S-1 treatment on efficacy of liposomal irinotecan plus 5-fluorouracil and leucovorin in patients with metastatic pancreatic cancer	Pancreatology. 2024 May;24(3):600-607.
2024-02-15	Neuron-derived neurotensin promotes pancreatic cancer invasiveness and gemcitabine resistance via the NTSR1/Akt pathway	American Journal of Cancer Research. 2024 Feb 15;14(2):448-466.
2024-02-13	Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: A multicenter study in Taiwan	Journal of Biomedical Science. 2024 Feb 13;31:Article number 21.
2024-02-01	Outcomes of post-immunotherapy durable responders of advanced hepatocellular carcinoma- with emphasis on locoregional therapy for oligoprogression	Liver Cancer. 2024 Feb 01;Article in Press.
2023-09-01	The experience of neoadjuvant chemotherapy versus upfront surgery in resectable pancreatic cancer. a cross sectional study	International Journal of Surgery. 2023 Sep 1;109(9):2614-2623.

Showing items 1-10 of 32. (4 Page(s) Totally) 1 2 3 4 > >> View [10|25|50] records per page